REFERENCES
1. Kociol RD, Cooper LT, Fang JC, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the american heart association. Circulation. 2020;141:e69-92.
2. Drazner MH, Bozkurt B, Cooper LT, et al. 2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2025;85:391-431.
3. Ammirati E, Frigerio M, Adler ED, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13:e007405.
4. Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025;46:3952-4041.
5. Nunez JI, Grandin EW, Reyes-Castro T, et al. Outcomes with peripheral venoarterial extracorporeal membrane oxygenation for suspected acute myocarditis: 10-year experience from the extracorporeal life support organization registry. Circ Heart Fail. 2023;16:e010152.
6. Schmidt M, Ponnaiah M, Huang F, et al. Temporary mechanical support in fulminant myocarditis: prognostic factors and clinical implications from the FULLMOON study. Intensive Care Med. 2026;52:240-51.
7. Tschöpe C, Ammirati E, Bozkurt B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2020;18:169-93.
8. Ammirati E, Cartella I, Varrenti M, et al. Acute myocarditis: 2024 state of the art. Eu Heart J Suppl. 2025;27:i56-60.
9. Schwab I, Nimmerjahn F. Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol. 2013;13:176-89.
10. Danieli MG, Antonelli E, Gammeri L, et al. Intravenous immunoglobulin as a therapy for autoimmune conditions. Autoimmun Rev. 2025;24:103710.
11. Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP; Cochrane Heart Group. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev. 2020;8:CD004370.
12. Mcnamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254-9.
13. Huang X, Sun Y, Su G, Li Y, Shuai X. Intravenous immunoglobulin therapy for acute myocarditis in children and adults: a meta-analysis. Int Heart J. 2019;60:359-65.
14. Zhou N, Zhao Y, Jiang J, et al. Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis. Sig Transduct Target Ther. 2021;6:350.
15. Yu D, Wang Y, Ma G, et al. Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: a retrospective study. Exp Ther Med. 2014;7:97-102.
16. Thai TBT, Kang Y, Nguyen HS, et al. Effect of intravenous immunoglobulin and steroids in acute myocarditis in children: a systematic review and network meta-analysis. Pediatr Res. 2026:4655.
17. Nimmerjahn F, Ravetch JV. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol. 2008;26:513-33.
18. Shock A, Humphreys D, Nimmerjahn F. Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: lessons from therapeutic modalities targeting Fcγ receptors. J Allergy Clin Immunol. 2020;146:492-500.
19. Leuschner F, Courties G, Dutta P, et al. Silencing of CCR2 in myocarditis. Eur Heart J. 2015;36:1478-88.
20. Wang Y, Chen J, Yu S, et al. Neutrophil CAPNS1 regulates cardiac inflammation and injury by promoting NETosis in CVB3-induced myocarditis. Free Radic Biol Med. 2026;248:500-15.
21. Mantri M, Hinchman MM, Mckellar DW, et al. Spatiotemporal transcriptomics reveals pathogenesis of viral myocarditis. Nat Cardiovasc Res. 2022;1:946-60.
22. Ueda T, Amiya E, Hatano M, et al. Prognostic factors associated with early recovery from veno‐arterial extracorporeal membrane oxygenation support in patients with fulminant myocarditis. J Am Heart Assoc. 2025;14:e039673.
23. Hsu HR, Sekhar P, Grover J, et al. Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation (V-A ECMO): a systematic review and meta-analysis. PLoS ONE. 2025;20:e0310289.
24. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216-33.
25. Baumeier C, Harms D, Aleshcheva G, Gross U, Escher F, Schultheiss H. Advancing precision medicine in myocarditis: current status and future perspectives in endomyocardial biopsy-based diagnostics and therapeutic approaches. J Clin Med. 2023;12:5050.
26. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation. J Am Coll Cardiol. 2018;72:3158-76.
27. Caobelli F, Cabrero JB, Galea N, et al. Cardiovascular magnetic resonance (CMR) and positron emission tomography (PET) imaging in the diagnosis and follow-up of patients with acute myocarditis and chronic inflammatory cardiomyopathy: a review paper with practical recommendations on behalf of the European Society of Cardiovascular Radiology (ESCR). Int J Cardiovasc Imaging. 2023;39:2221-35.
28. Caforio ALP, Kaski JP, Gimeno JR, et al. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry. Eur Heart J. 2024;45:2548-69.
29. Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323:2417.
30. Hernán MA, Sauer BC, Hernández-Díaz S, Platt R, Shrier I. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. J Clin Epidemiol. 2016;79:70-5.
31. Ammann EM, Haskins CB, Fillman KM, et al. Intravenous immune globulin and thromboembolic adverse events: a systematic review and meta‐analysis of RCTs. Am J Hematol. 2016;91:594-605.
